AlloSource's ProChondrix receives patent — 4 highlights

Spinal Tech

AlloSource received a patent for its new cartilage repair allograft, ProChondrix Cartilage Restoration Matrix.

Here are four highlights:

 

1. ProChondrix is a cellular 3-D fresh cartilage matrix that helps deliver the necessary components for cartilage restoration.

 

2. AlloSource Vice President of development and growth, Peter Stevens, PhD, said the initial feedback from surgeons on ProChondrix has been positive.

 

3. This next generation of cartilage therapy provides live functional cells and other biological components necessary for repair and regeneration of damaged cartilage tissues.

 

4. Headquartered in Centennial, Colo., AlloSource is one of the largest nonprofit cellular and tissue networks in the country, offering more than 200 types of precise cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers